|
Q3 FY2016
As of Dec 31, 2015
|
Q2 FY2016
As of Sep 30, 2015
|
Q1 FY2016
As of Jun 30, 2015
|
Q4 FY2015
As of Mar 31, 2015
|
Q3 FY2015
As of Dec 31, 2014
|
Q2 FY2015
As of Sep 30, 2014
|
Q1 FY2015
As of Jul 31, 2014
|
Q4 FY2014
As of Apr 30, 2014
|
Q3 FY2014
As of Jan 31, 2014
|
Q2 FY2014
As of Oct 31, 2013
|
Q1 FY2014
As of Jul 31, 2013
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| CURRENT ASSETS | |||||||||||
| Cash | |||||||||||
| Accounts receivable, net of allowance for doubtful accounts of $0 and $5,184 at December 31, 2015 and March 31, 2015, respectively | |||||||||||
| Inventory | |||||||||||
| Prepaid expenses | |||||||||||
| Fair value of derivatives on convertible debt | |||||||||||
| Total Current Assets | |||||||||||
| Trademark, net of $728 and $288 in accumulated amortization at December 31, 2015 and March 31, 2015, respectively | |||||||||||
| Total Assets | |||||||||||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | |||||||||||
| CURRENT LIABILITIES | |||||||||||
| Accounts payable | |||||||||||
| Notes payable | |||||||||||
| Accrued liabilities | |||||||||||
| Accrued Interest | |||||||||||
| Short-term debt, net of deferred financing fees,net of $23,521 at December 31, 2015 and nil at March 31, 2015, respectively | |||||||||||
| Fair value of derivatives on convertible debt | |||||||||||
| Due to Shareholder | |||||||||||
| Total Current Liabilities | |||||||||||
| Total Liabilities | |||||||||||
| STOCKHOLDERS' DEFICIT | |||||||||||
| Common stock, $0.001 par value, 500,000,000 shares authorized, 297,038,096 and 114,050,000 shares issued and outstanding as of December 31, 2015 and March 31, 2015, respectively | |||||||||||
| Additional paid-in capital | |||||||||||
| Accumulated deficit | |||||||||||
| Total Stockholders' Deficit | |||||||||||
| Total Liabilities and Stockholders' Deficit |
Loading...
